Venture Visionary Partners LLC Novartis Ag Transaction History

Venture Visionary Partners LLC

  • $2.29 Billion
  • Q1 2025

A detailed history of Venture Visionary Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Venture Visionary Partners LLC holds 10,914 shares of NVS stock, worth $1.26 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,914
Previous 10,936 0.2%
Holding current value
$1.26 Million
Previous $1.06 Million 14.29%
% of portfolio
0.05%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$97.14 - $115.57 $2,137 - $2,542
-22 Reduced 0.2%
10,914 $1.22 Million
Q4 2024

Feb 12, 2025
BUY
$96.78 - $117.18 $2,516 - $3,046
26 Added 0.24%
10,936 $1.06 Million
Q3 2024

Oct 21, 2024
SELL
$106.13 - $120.89 $63,253 - $72,050
-596 Reduced 5.18%
10,910 $1.25 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $3,517 - $4,080
-38 Reduced 0.33%
11,506 $1.22 Million
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $38,108 - $43,388
400 Added 3.59%
11,544 $1.12 Million
Q4 2023

Feb 15, 2024
BUY
$92.27 - $101.54 $13,102 - $14,418
142 Added 1.29%
11,144 $1.13 Million
Q4 2023

Jan 24, 2024
SELL
$92.27 - $101.54 $24,451 - $26,908
-265 Reduced 2.35%
11,002 $1.11 Million
Q2 2023

Jul 14, 2023
SELL
$92.52 - $104.91 $67,447 - $76,479
-729 Reduced 6.08%
11,267 $1.14 Million
Q1 2023

Apr 13, 2023
SELL
$80.03 - $92.81 $77,389 - $89,747
-967 Reduced 7.46%
11,996 $1.1 Million
Q4 2022

Feb 09, 2023
BUY
$75.55 - $92.52 $76,381 - $93,537
1,011 Added 8.46%
12,963 $1.18 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $6,118 - $7,155
-82 Reduced 0.68%
11,952 $908,000
Q2 2022

Jul 26, 2022
SELL
$80.52 - $93.75 $44,688 - $52,031
-555 Reduced 4.41%
12,034 $1.02 Million
Q1 2022

May 03, 2022
SELL
$80.11 - $90.62 $34,607 - $39,147
-432 Reduced 3.32%
12,589 $1.1 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $52,203 - $57,725
-655 Reduced 4.79%
13,021 $1.14 Million
Q3 2021

Oct 20, 2021
SELL
$81.78 - $95.14 $74,419 - $86,577
-910 Reduced 6.24%
13,676 $1.09 Million
Q2 2021

Aug 05, 2021
SELL
$85.24 - $94.15 $206,280 - $227,843
-2,420 Reduced 14.23%
14,586 $1.33 Million
Q1 2021

Apr 27, 2021
SELL
$83.5 - $98.47 $64,545 - $76,117
-773 Reduced 4.35%
17,006 $1.45 Million
Q4 2020

Jan 27, 2021
BUY
$78.07 - $94.43 $965,491 - $1.17 Million
12,367 Added 228.51%
17,779 $1.68 Million
Q3 2020

Oct 22, 2020
BUY
$82.14 - $91.0 $157,215 - $174,174
1,914 Added 54.72%
5,412 $489,000
Q2 2020

Aug 11, 2020
BUY
$80.93 - $91.1 $79,958 - $90,006
988 Added 39.36%
3,498 $305,000
Q1 2020

May 07, 2020
BUY
$70.67 - $99.01 $14,982 - $20,990
212 Added 9.23%
2,510 $206,000
Q4 2019

Feb 06, 2020
BUY
$84.35 - $95.37 $193,836 - $219,160
2,298 New
2,298 $217,000

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email